refractory to conventional therapy
1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.064 mg, 0.048 mg, 0.032 mg, 40.0 mg/mL, , 0.016 mg, 0.125 mg, 0.25 mg, 1.0 mg, 10.0 mg/mL, 2.0 mg/mL, 20.0 mg/mL, 5.0 mg, 2.5 mg, 1.74 mg/mL
Solution, Inhalant, Solution - Intravenous; Subcutaneous, , Kit; Tablet, extended release - Oral, Injection, solution, Oral, Kit; Tablet, extended release, Inhalant; Kit - Oral, Injection, Injection, solution - Intravenous; Subcutaneous, Inhalant - Respiratory (inhalation), Tablet, extended release - Oral, Injection, solution - Subcutaneous, Intravenous; Subcutaneous, Inhalant - Oral, Tablet, extended release, Inhalant; Kit, Respiratory (inhalation), Injection - Intravenous; Subcutaneous, Subcutaneous
NYHA class IV
1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.064 mg, 0.048 mg, 0.032 mg, 40.0 mg/mL, , 0.016 mg, 0.125 mg, 0.25 mg, 1.0 mg, 10.0 mg/mL, 2.0 mg/mL, 20.0 mg/mL, 5.0 mg, 2.5 mg, 1.74 mg/mL
Solution, Inhalant, Solution - Intravenous; Subcutaneous, , Kit; Tablet, extended release - Oral, Injection, solution, Oral, Kit; Tablet, extended release, Inhalant; Kit - Oral, Injection, Injection, solution - Intravenous; Subcutaneous, Inhalant - Respiratory (inhalation), Tablet, extended release - Oral, Injection, solution - Subcutaneous, Intravenous; Subcutaneous, Inhalant - Oral, Tablet, extended release, Inhalant; Kit, Respiratory (inhalation), Injection - Intravenous; Subcutaneous, Subcutaneous
NYHA Functional Class III Pulmonary arterial hypertension
1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.064 mg, 0.048 mg, 0.032 mg, 40.0 mg/mL, , 0.016 mg, 0.125 mg, 0.25 mg, 1.0 mg, 10.0 mg/mL, 2.0 mg/mL, 20.0 mg/mL, 5.0 mg, 2.5 mg, 1.74 mg/mL
Solution, Inhalant, Solution - Intravenous; Subcutaneous, , Kit; Tablet, extended release - Oral, Injection, solution, Oral, Kit; Tablet, extended release, Inhalant; Kit - Oral, Injection, Injection, solution - Intravenous; Subcutaneous, Inhalant - Respiratory (inhalation), Tablet, extended release - Oral, Injection, solution - Subcutaneous, Intravenous; Subcutaneous, Inhalant - Oral, Tablet, extended release, Inhalant; Kit, Respiratory (inhalation), Injection - Intravenous; Subcutaneous, Subcutaneous
WHO functional class II-III Pulmonary arterial hypertension
1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.064 mg, 0.048 mg, 0.032 mg, 40.0 mg/mL, , 0.016 mg, 0.125 mg, 0.25 mg, 1.0 mg, 10.0 mg/mL, 2.0 mg/mL, 20.0 mg/mL, 5.0 mg, 2.5 mg, 1.74 mg/mL
Solution, Inhalant, Solution - Intravenous; Subcutaneous, , Kit; Tablet, extended release - Oral, Injection, solution, Oral, Kit; Tablet, extended release, Inhalant; Kit - Oral, Injection, Injection, solution - Intravenous; Subcutaneous, Inhalant - Respiratory (inhalation), Tablet, extended release - Oral, Injection, solution - Subcutaneous, Intravenous; Subcutaneous, Inhalant - Oral, Tablet, extended release, Inhalant; Kit, Respiratory (inhalation), Injection - Intravenous; Subcutaneous, Subcutaneous
Pulmonary Arterial Hypertension
1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.064 mg, 0.048 mg, 0.032 mg, 40.0 mg/mL, , 0.016 mg, 0.125 mg, 0.25 mg, 1.0 mg, 10.0 mg/mL, 2.0 mg/mL, 20.0 mg/mL, 5.0 mg, 2.5 mg, 1.74 mg/mL
Solution, Inhalant, Solution - Intravenous; Subcutaneous, , Kit; Tablet, extended release - Oral, Injection, solution, Oral, Kit; Tablet, extended release, Inhalant; Kit - Oral, Injection, Injection, solution - Intravenous; Subcutaneous, Inhalant - Respiratory (inhalation), Tablet, extended release - Oral, Injection, solution - Subcutaneous, Intravenous; Subcutaneous, Inhalant - Oral, Tablet, extended release, Inhalant; Kit, Respiratory (inhalation), Injection - Intravenous; Subcutaneous, Subcutaneous
NYHA Functional Class III
1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.064 mg, 0.048 mg, 0.032 mg, 40.0 mg/mL, , 0.016 mg, 0.125 mg, 0.25 mg, 1.0 mg, 10.0 mg/mL, 2.0 mg/mL, 20.0 mg/mL, 5.0 mg, 2.5 mg, 1.74 mg/mL
Solution, Inhalant, Solution - Intravenous; Subcutaneous, , Kit; Tablet, extended release - Oral, Injection, solution, Oral, Kit; Tablet, extended release, Inhalant; Kit - Oral, Injection, Injection, solution - Intravenous; Subcutaneous, Inhalant - Respiratory (inhalation), Tablet, extended release - Oral, Injection, solution - Subcutaneous, Intravenous; Subcutaneous, Inhalant - Oral, Tablet, extended release, Inhalant; Kit, Respiratory (inhalation), Injection - Intravenous; Subcutaneous, Subcutaneous
Pulmonary Arterial Hypertension
1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.064 mg, 0.048 mg, 0.032 mg, 40.0 mg/mL, , 0.016 mg, 0.125 mg, 0.25 mg, 1.0 mg, 10.0 mg/mL, 2.0 mg/mL, 20.0 mg/mL, 5.0 mg, 2.5 mg, 1.74 mg/mL
Solution, Inhalant, Solution - Intravenous; Subcutaneous, , Kit; Tablet, extended release - Oral, Injection, solution, Oral, Kit; Tablet, extended release, Inhalant; Kit - Oral, Injection, Injection, solution - Intravenous; Subcutaneous, Inhalant - Respiratory (inhalation), Tablet, extended release - Oral, Injection, solution - Subcutaneous, Intravenous; Subcutaneous, Inhalant - Oral, Tablet, extended release, Inhalant; Kit, Respiratory (inhalation), Injection - Intravenous; Subcutaneous, Subcutaneous